Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
post
Last Updated on: 14 April, 2024|Author: Getaka | Social: X Twitter Profile

Fundamental Analysis of Aarti Drugs Limited

About the Company - Aarti Drugs Limited

Aarti Drugs Ltd. is a Public Limited Listed company incorporated on 28/09/1984 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L37060MH1984PLC055433 and registration number is 055433. Currently Company is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 2251.17 Cr. and Equity Capital is Rs. 92.60 Cr. for the Year ended 31/03/2022.
INDUSTRYADDRESSCONTACT
PharmaceuticalsPlot No. 198, M.I.D.C., Palghar District Maharashtra 401506investorrelations@aartidrugs.com
http://www.aartidrugs.co.in
Management
NamePosition Held
Mr. Chandrakant V GogriChairman Emeritus
Mr. Prakash M PatilChairman & M.D & CEO
Mr. Rashesh C GogriManaging Director
Mr. Harshit M SavlaJoint Managing Director
Mr. Harit P ShahExecutive Director
Mr. Uday M PatilExecutive Director
Mrs. Neha R GadaIndependent Director
CA. Navin C ShahIndependent Director
Dr. Krishnacharya G AkamanchiIndependent Director
Prof. Bhaskar N ThoratIndependent Director
Mrs. Priti P SavlaIndependent Director
Mr. Ankit V PalejaIndependent Director
Mr. Narendra J SalviNon Executive Director

Aarti Drugs Ltd. Share Price Update

Share PriceValue
Today₹501.35
Previous Day₹507.50

Basic Stock Data of Aarti Drugs Limited

Last Updated: April 9, 2024, 10:40 pm

Market Cap 4,488 Cr.
Current Price 488
High / Low646/375
Stock P/E28.3
Book Value 121
Dividend Yield0.20 %
ROCE15.3 %
ROE14.6 %
Face Value 10.0

Data Source: screener.in

Aarti Drugs Limited Quarterly Results

MonthDec 2020Mar 2021Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023
Sales472452506511593641551625626696592578538
Expenses374374432442503557496555557608520512478
Operating Profit98787469918455706989726560
OPM %21%17%15%14%15%13%10%11%11%13%12%11%11%
Other Income4121210011112
Interest5445567898887
Depreciation12121212121212121212121212
Profit before tax85636053756736504969534743
Tax %24%21%24%24%26%21%28%27%25%23%25%26%26%
Net Profit65504641565326373753403532
EPS in Rs6.945.394.924.396.035.722.853.953.965.744.273.763.44

Last Updated: April 6, 2024, 9:22 am

Aarti Drugs Limited Quarterly Chart

Aarti Drugs Limited Profit & Loss

MonthMar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023TTM
Sales6598269721,0871,0761,0891,1401,4541,6351,9152,2512,4982,491
Expenses5797038229159009109551,2521,3871,5111,9302,2122,196
Operating Profit80123150172176179185203248404321286295
OPM %12%15%15%16%16%16%16%14%15%21%14%11%12%
Other Income2-011041697523
Interest25313742473836413626233633
Depreciation24262831363738404748474747
Profit before tax32668610093108112128175338256205218
Tax %30%31%28%22%29%30%35%32%22%24%24%25%
Net Profit2245627866757387136258195153164
EPS in Rs2.324.676.388.016.847.917.789.2514.5627.6521.0616.5017.70
Dividend Payout %27%27%26%41%25%3%3%3%3%9%5%6%

Aarti Drugs Limited Profit & Loss Yearly Chart

Aarti Drugs Limited Growth

Compounded Sales Growth
10 Years:12%
5 Years:17%
3 Years:15%
TTM:-2%
Compounded Profit Growth
10 Years:13%
5 Years:16%
3 Years:6%
TTM:4%
Stock Price CAGR
10 Years:30%
5 Years:27%
3 Years:-11%
1 Year:29%
Return on Equity
10 Years:22%
5 Years:22%
3 Years:22%
Last Year:15%

Aarti Drugs Limited Balance Sheet

Last Updated: April 6, 2024, 9:22 am

MonthMar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Sep 2023
Equity Capital12121224242424242393939392
Reserves1641962392793263634104955987668801,0221,023
Borrowings272296342435465448517471378336519535500
Other Liabilities164216257228240281366384471442543546499
Total Liabilities6137208509671,0551,1161,3161,3731,4711,6372,0352,1952,114
Fixed Assets274291373431463542564586612631649634628
CWIP31381334142832111660161246
Investments75511111817192024282928
Other Assets3294114645115475417077368289661,2971,3721,212
Total Assets6137208509671,0551,1161,3161,3731,4711,6372,0352,1952,114

Aarti Drugs Limited Reserves and Borrowings Chart

Aarti Drugs Limited Cash Flow

MonthMar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023
Cash from Operating Activity 4472951071251746214719615440162
Cash from Investing Activity -48-58-105-102-87-96-71-59-29-69-125-131
Cash from Financing Activity 3-1611-5-37-789-87-168-8584-31
Net Cash Flow-0-22-11-0-01-1-0-11

Aarti Drugs Limited Financial Efficiency Indicators

MonthMar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023
Debtor Days100951041031099311711010496115117
Inventory Days809571778710113286107125120102
Days Payable778884758591125861109410389
Cash Conversion Cycle10310191105110103124109101127133130
Working Capital Days105101909710810312810895118132130
ROCE %14%20%22%21%18%17%17%17%20%33%21%15%

Aarti Drugs Limited Financial Efficiency Indicators Chart

Aarti Drugs Limited Share Holding Pattern

MonthMar 2021Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023
Promoters60.20%60.14%60.12%59.99%59.83%59.98%59.77%59.66%59.57%58.70%58.57%57.47%
FIIs2.99%2.57%2.21%2.03%2.07%2.07%1.94%1.90%1.94%1.97%2.33%2.10%
DIIs1.76%2.00%2.12%2.28%2.69%2.76%3.16%3.90%4.09%4.72%5.32%5.26%
Public35.05%35.29%35.55%35.71%35.41%35.19%35.11%34.53%34.39%34.63%33.78%35.16%
No. of Shareholders1,73,7041,77,9931,83,3441,95,4691,89,6071,86,6741,80,3031,73,2831,69,0901,62,4091,67,4461,70,414

Aarti Drugs Limited Shareholding Pattern Chart

No. of Aarti Drugs Limited Shareholders

Aarti Drugs Limited Mutual Fund Holdings

Fund NameNo of SharesAUM (%)Amount Invested (Cr)
Quant Business Cycle Fund3410002.4916.01
Quant Healthcare Fund1410004.16.62
Nippon India Nifty Smallcap 250 Index Fund194480.130.91
ICICI Prudential Nifty Smallcap 250 Index Fund45580.140.25
HDFC NIFTY Smallcap 250 ETF20810.140.11
HDFC Nifty Smallcap 250 Index Fund16130.140.09
ICICI Prudential S&P BSE 500 ETF2990.010.02
HDFC S&P BSE 500 ETF160.010
HDFC S&P BSE 500 Index Fund410.010

Aarti Drugs Limited ROCE Trend

Aarti Drugs Limited EPS Trend

Aarti Drugs Limited Key Financial Ratios

MonthMar 23Mar 22Mar 21Mar 20Mar 19
FaceValue10.0010.0010.0010.0010.00
Basic EPS (Rs.)17.9722.1230.0960.5738.48
Diluted EPS (Rs.)17.9722.1230.0960.5738.48
Cash EPS (Rs.)23.4027.5435.4481.6156.11
Book Value[Excl.RevalReserv]/Share (Rs.)128.80111.9198.00280.04230.45
Book Value[Incl.RevalReserv]/Share (Rs.)128.80111.9198.00280.04230.45
Revenue From Operations / Share (Rs.)293.31268.75231.20775.14661.92
PBDIT / Share (Rs.)33.2436.8047.38113.0088.96
PBIT / Share (Rs.)27.8131.3942.0392.0870.91
PBT / Share (Rs.)24.2129.1539.5979.5255.56
Net Profit / Share (Rs.)17.9722.1430.0960.6938.06
NP After MI And SOA / Share (Rs.)17.9622.1430.0960.6938.06
PBDIT Margin (%)11.3313.6920.4914.5713.43
PBIT Margin (%)9.4711.6818.1811.8710.71
PBT Margin (%)8.2510.8417.1210.258.39
Net Profit Margin (%)6.128.2313.017.825.74
NP After MI And SOA Margin (%)6.128.2313.017.825.74
Return on Networth / Equity (%)13.9419.7830.6921.6716.51
Return on Capital Employeed (%)17.2922.9233.4622.5419.34
Return On Assets (%)6.869.2815.878.966.16
Long Term Debt / Equity (X)0.170.130.160.270.38
Total Debt / Equity (X)0.500.510.330.510.86
Asset Turnover Ratio (%)1.171.181.191.121.05
Current Ratio (X)1.601.481.771.451.33
Quick Ratio (X)1.050.921.080.920.90
Inventory Turnover Ratio (X)3.393.373.153.893.68
Dividend Payout Ratio (NP) (%)5.564.518.304.942.62
Dividend Payout Ratio (CP) (%)4.273.637.053.671.78
Earning Retention Ratio (%)94.4495.4991.7095.0697.38
Cash Earning Retention Ratio (%)95.7396.3792.9596.3398.22
Interest Coverage Ratio (X)9.2516.4219.247.815.25
Interest Coverage Ratio (Post Tax) (X)6.0010.8813.205.063.15
Enterprise Value (Cr.)3725.824488.496770.511508.911976.21
EV / Net Operating Revenue (X)1.371.803.140.831.27
EV / EBITDA (X)12.1013.1715.335.739.42
MarketCap / Net Operating Revenue (X)1.151.603.010.650.96
Retention Ratios (%)94.4395.4891.6995.0597.37
Price / BV (X)2.623.837.091.812.78
Price / Net Operating Revenue (X)1.151.603.010.650.96
EarningsYield0.050.050.040.110.05

Aarti Drugs Limited Profitability Ratios (%)

Aarti Drugs Limited Liquidity Ratios

Aarti Drugs Limited Liquidity Ratios (%)

Aarti Drugs Limited Interest Coverage Ratios (%)

Aarti Drugs Limited Valuation Ratios

Fair Value of Aarti Drugs Limited Stock

Fair Value: 500.95

The stock is undervalued by 2.65% compared to the current price ₹488

Calculation basis:

  • Fair value = (P/E Ratio * (Return on Equity / 100) * Book Value) * (1 + Dividend Yield / 100)
  • P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
  • Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance
  • Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
  • Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.

This formula allows us to gauge the fair value of the stock by analyzing its fundamental indicators.

*Investments are subject to market risks

Strength and Weakness of Aarti Drugs Limited Stock

StrengthWeakness
  1. The stock has a high average ROCE of 19.58%, which is a positive sign.
  2. The company has higher reserves (520.08 cr) compared to borrowings (424.15 cr), indicating strong financial stability.
  3. The company has shown consistent growth in sales (190.00 cr) and profit (147.46 cr) over the years.
  1. The stock has a high average Working Capital Days of 109.58, which may not be favorable.
  2. The stock has a high average Cash Conversion Cycle of 111.42, which may not be favorable.

FAQ

What is the latest fair value of Aarti Drugs Limited?

The latest fair value of Aarti Drugs Limited is 500.95.

What is the Market Cap of Aarti Drugs Limited?

The Market Cap of Aarti Drugs Limited is 4,488 Cr..

What is the current Stock Price of Aarti Drugs Limited as on 13 April 2024?

The current stock price of Aarti Drugs Limited as on 13 April 2024 is 488.

What is the High / Low of Aarti Drugs Limited stocks in FY 2024?

In FY 2024, the High / Low of Aarti Drugs Limited stocks is ₹646/375.

What is the Stock P/E of Aarti Drugs Limited?

The Stock P/E of Aarti Drugs Limited is 28.3.

What is the Book Value of Aarti Drugs Limited?

The Book Value of Aarti Drugs Limited is 121.

What is the Dividend Yield of Aarti Drugs Limited?

The Dividend Yield of Aarti Drugs Limited is 0.20 %.

What is the ROCE of Aarti Drugs Limited?

The ROCE of Aarti Drugs Limited is 15.3 %.

What is the ROE of Aarti Drugs Limited?

The ROE of Aarti Drugs Limited is 14.6 %.

What is the Face Value of Aarti Drugs Limited?

The Face Value of Aarti Drugs Limited is 10.0.

About the Author

Author Avatar
Getaka

Getaka, CFA, a financial analyst with 15 years of experience in the industry. Getaka holds an MBA degree and the Chartered Financial Analyst designation, demonstrating his profound understanding of financial analysis and investment management. Throughout his career, he has conducted numerous financial analyses and due diligence processes for companies in the industry, and has a strong track record of identifying key trends and opportunities. He leverages his expertise to deliver a thorough financial analysis of a company, encompassing its financial performance, key ratios, future prospects, and risks. Getaka is committed to providing accurate, reliable, and trustworthy information to help readers make informed decisions about their finances and investments.

Disclaimer: This article is for informational purposes only and should not be construed as financial advice. The author is not a SEBI registered financial advisor and does not have any vested interest in Aarti Drugs Limited. Investors are advised to conduct their own due diligence and consult with a financial professional before making any investment decisions. The information provided in this article is based on publicly available data and the author's analysis, but it may not be comprehensive or up-to-date. The author and getaka.co.in are not responsible for any errors or omissions in the content. This article is not intended to promote any particular investment strategy or recommendation, and readers should consult with their own financial advisors before making any investment decisions. Data Source: NSE